Bilateral serous retinal detachment and uveitis associated with pembrolizumab treatment in metastatic melanoma

Conclusion: Pembrolizumab therapy may cause the development of panuveitis, papillitis, and serous retinal detachment, symptoms which are able to be controlled with lengthy steroid therapy.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research